AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19 - Yahoo Finance UK
AB Stock | EUR 0.79 0.01 1.25% |
About 62% of AB Science's investor base is looking to short. The analysis of current outlook of investing in AB Science SA suggests that many traders are alarmed regarding AB Science's prospects. The current market sentiment, together with AB Science's historical and current headlines, can help investors time the market. In addition, many technical investors use AB Science SA stock news signals to limit their universe of possible portfolio assets.
AB Science |
AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19 Yahoo Finance UK
Read at news.google.com
AB Science Fundamental Analysis
We analyze AB Science's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AB Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AB Science based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
AB Science is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
AB Science SA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AB Science stock to make a market-neutral strategy. Peer analysis of AB Science could also be used in its relative valuation, which is a method of valuing AB Science by comparing valuation metrics with similar companies.
Peers
AB Science Related Equities
NANO | Nanobiotix | 0.36 | ||||
GNFT | Genfit | 2.92 | ||||
IPH | Innate Pharma | 4.90 | ||||
ADOC | Adocia | 6.26 |
Complementary Tools for AB Science Stock analysis
When running AB Science's price analysis, check to measure AB Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB Science is operating at the current time. Most of AB Science's value examination focuses on studying past and present price action to predict the probability of AB Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB Science's price. Additionally, you may evaluate how the addition of AB Science to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |